James E. Levine - Chief Financial Officer at Cardiff Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
CRDF on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James E. Levine since 12 Mar 2025

Holdings reported by James E. Levine for Cardiff Oncology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 67,716 $338,580 $5.00 18 Dec 2024 By Wife
Stock Options 1,295,117 11 Mar 2025 Direct Common Stock

Transactions reported by James E. Levine for Cardiff Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.